From: Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia
Multivariate analysis
HR (95% CI)
P value
Age (year)
1.04 (1.01–1.08)
0.022
Male
2.13 (0.94–4.79)
0.068
FVC % predicted (%)
0.95 (0.93–0.98)
< 0.001
BAL lymphocytosis
0.31 (0.13–0.75)
0.009
Anti-fibrotic drugs
1.94 (0.90–4.19)
0.090